MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Influence of major earthquakes and their effects on patients with Parkinson’s disease: A multi-institutional study

    R. Kurisaki, H. Ueyama, Y. Maeda, T. Sakamoto, K. Nakahara, S. Nakane, S. Yamashita, Y. Ando (Koshi, Japan)

    Objective: To investigate the effects of major earthquakes on patients with Parkinson's disease (PD). Background: On April 14 and 16, 2016, two major earthquakes (“The…
  • 2017 International Congress

    Associations of probable REM sleep behavior disorder, constipation, and hyposmia with PD

    K. Hughes, X. Gao, J. Baker, M. Schwarzschild, A. Ascherio (Boston, MA, USA)

    Objective: To estimate the relative risk of PD according to combinations of prodromal features. Background: Clinical PD is preceded by a prodromal period characterized by…
  • 2017 International Congress

    Sex Differences in Homebound Advanced Parkinson’s Disease Patients

    L. Nwabuobi, W. Barbosa, M. Sweeney, S. Oyler, A. Lemen, T. Meisel, A. Di Rocco, J. Chodosh, J. Fleisher (New York, NY, USA)

    Objective: To describe sex differences in homebound patients with advanced Parkinson’s disease and related disorders in an interdisciplinary home visit program (HVP) Background: It has…
  • 2017 International Congress

    The value of various risk factors in the manifestation of Parkinson’s disease in the southern part of Uzbekistan.

    S. Lukmonov (Tashkent, Uzbekistan)

    Objective: Using a comprehensive analysis of clinical, medical history and social - hygienic data will examine the factors that determine the development of Parkinson's disease.…
  • 2017 International Congress

    Dr. Paula Coutinho’s Seminal Contributions to the Understanding of Machado-Joseph’s Disease

    P. Marques, H. Teive, F. Germiniani, B. Garcia (Curitiba, Brazil)

    Objective: To recognize the contributions of Dr. Paula Coutinho to Neurology through her studies of Machado-Joseph’s disease (SCA3)  Background: One of the unique opportunities in…
  • 2017 International Congress

    Safinamide improves both motor and non-motor symptoms in fluctuating Parkinson’s Disease patients.

    C. Cattaneo (Bresso (Milan), Italy)

    Objective: To investigate the efficacy of safinamide, compared to placebo, as add-on therapy to stable doses of levodopa, on both motor and non-motor symptoms in…
  • 2017 International Congress

    Clinical characteristics of Parkinson’s disease developed from essential tremor

    D.-W. Ryu, J.-S. Kim, K.-S. Lee, J.-W. Park (Seoul, Republic of Korea)

    Objective: The objective of this study is to compare the clinical characteristics of Parkinson’s disease developed from essential tremor (ET-PD) with the clinical characteristics of…
  • 2017 International Congress

    Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression

    E. Dalle, D. William, M. Musa (Durban, South Africa)

    Objective: The objective of this study was to investigate how fluvoxamine maleate treatment regulates depressive-like symptoms, motor impairments and the expressions of IL-1beta, IL-6, IL-10…
  • 2017 International Congress

    Investigation of Non-Motor Symptoms Impacting Care Dependency in Individuals with Parkinson’s Disease

    M. Bryant, A. Tan, J.-G. Hou, E. Protas (Houston, TX, USA)

    Objective: To examine what extent non-motor symptoms of Parkinson’s disease (PD) predict care dependence in individuals with PD. Background: The main aim of medical management…
  • 2017 International Congress

    Interrelation between chronic pain syndrome and cognitive and affective disturbances in patients with Parkinson’s disease

    K. Stepanchenko (Kharkiv, Ukraine)

    Objective: To study interrelation of chronic pain syndrome and cognitive and affective disorders in patients with PD Background: Parkinson's disease (PD) is characterized by well-known…
  • « Previous Page
  • 1
  • …
  • 1196
  • 1197
  • 1198
  • 1199
  • 1200
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25676 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley